Ignite Creation Date:
2024-05-06 @ 8:22 AM
Last Modification Date:
2024-10-26 @ 11:59 AM
Study NCT ID:
NCT02729961
Status:
WITHDRAWN
Last Update Posted:
2019-10-10
First Post:
2016-03-29
Brief Title:
Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma
Sponsor:
University of Washington
Organization:
University of Washington
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-03
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2016-03-29
First Submit QC Date:
March 31 2016
Study First Post Date:
2016-04-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-08
Last Update Post Date:
2019-10-10
Last Update Post Date Type:
ACTUAL